Concise source Source status Β· 1 documents Β· Completeness: 27%
- Allegato_3_-_Offerta_economica.pdf (offerta_economica, 3 pp.)
βΉοΈ Concise source (notice/market survey or single annex): data such as CIG, guarantees, ANAC, stamp duty appear only in the full tender's disciplinare, not yet available here. 'Not stated' fields reflect the document, not a gap in the analysis.
π‘ TO EVALUATE
Focus: coagulazione POCT Β· Deadline: N/A Β· Exclusivity risk: medium
In focus (POCT coagulation) but the tender documentation in the dossier is incomplete (only the economic offer): deadline and CIG unknown; verify the availability of the ACT-LR product and the specifications on SINTEL.
π― Merit only (ignore deadline): TO EVALUATE β ACT rental with requirements that are not excluding based on the available data: a potentially contestable opportunity, to be verified against the Firsteck portfolio (ACT-LR system for ECMO).
TENDER ANALYSIS No. 2026-04_ASST_Melegnano
Document generated on 04/06/26 12:44
TENDER IDENTIFICATION DATA
| TENDER SUBJECT | Rental supply of equipment for ACT measurement and related kits for the analysis of the coagulation timeSource: Allegato_3_-_Offerta_economica.pdf: pagina 1 |
| CONTRACTING AUTHORITY | ASST Melegnano e della Martesana - Procurement Department, Via Pandina 1, 20070 Vizzolo Predabissi (MI)Source: Allegato_3_-_Offerta_economica.pdf: pagina 1 |
| CIG (tender ID) | Not stated |
| PROCEDURE TYPE | Request for offer pursuant to art. 50, paragraph 1, letter b) of Legislative Decree 36/2023 (direct award / RfO)Source: Allegato_3_-_Offerta_economica.pdf: pagina 1 |
| PLATFORM | SINTEL platform by ARIA SpASource: Allegato_3_-_Offerta_economica.pdf: pagina 1 |
| PLACE OF PERFORMANCE | ASST Melegnano e della Martesana (sites: Via G. Maestri 2, 20077 Melegnano; Via Pandina 1, 20070 Vizzolo Predabissi MI)Source: Allegato_3_-_Offerta_economica.pdf: pagina 1 |
| AWARD CRITERION | Not stated |
| BID SUBMISSION DEADLINE | Not stated |
| TOTAL AMOUNT | β¬ 97.977,00 (VAT excluded) total amount of the negotiation base for 60 monthsSource: Allegato_3_-_Offerta_economica.pdf: pagina 2 |
| PNRR (recovery funds) | Not stated |
PARTICIPATION REQUIREMENTS
| ELIGIBILITY REQUIREMENTS | Not stated |
| ECONOMIC CAPACITY | Not stated |
| TECHNICAL CAPACITY | Not stated |
| SOA CATEGORY | Not stated |
| CREDIT LICENCE | Not stated |
| ADDITIONAL REQUIREMENTS | Not stated |
| WHITE LIST | Not stated |
PRELIMINARY OBLIGATIONS
| BID BOND | Not stated |
| ANAC FEE | Not stated |
| SITE INSPECTION | Not stated |
| SAMPLING | Not stated |
| TIMESTAMP / DIGITAL SIGNATURE | Not stated |
| TECHNICAL OFFER | Not stated |
| STAMP DUTY | Not stated |
| LABOUR CONTRACT (CCNL) | Indication of the collective bargaining agreement applicable to the employed personnel is required (art. 11 of Legislative Decree 36/2023, paragraph 2, as amended by Legislative Decree 209/2024)Source: Allegato_3_-_Offerta_economica.pdf: pagina 3 |
| ACCELERATION BONUS | Not stated |
| SUBCONTRACTING | Not stated |
| RELIANCE (avvalimento) | Not stated |
| RTI / CONSORTIUM | Not stated |
| CLARIFICATIONS DEADLINE | Not stated |
| FVOE (virtual file) | Not stated |
| BID VALIDITY | 180 daysSource: Allegato_3_-_Offerta_economica.pdf: pagina 3 |
Custom questions
Only Annex 3 (economic offer) is available: the tender regulations and specifications are missing. Where can the CIG, the award criterion, the deadlines and the participation requirements be found?
The dossier contains only the economic offer template; all administrative data must be retrieved from the tender documentation on SINTEL. Source: Allegato_3_-_Offerta_economica.pdf: pagina 1
The supply is a 60-month rental: does Firsteck have its own ACT instrumentation, or through a partner, for the five-year rental?
To be verified internally. Source: Allegato_3_-_Offerta_economica.pdf: pagina 2
The requested ACT-LR kits must be compatible with the offered instrumentation: does the Firsteck solution cover ECMO, hemodynamics, vascular/neuro-interventional procedures and dialysis?
To be verified on the product portfolio. Source: Allegato_3_-_Offerta_economica.pdf: pagina 2
TECHNICAL ANALYSIS
Subject: Rental supply of equipment for ACT measurement and related kits for the analysis of the activated clotting timeTotal base amount: β¬ 97.977,00 (VAT excluded, 60 months)No. of lots: 1
LOT 1 β Rental system for ACT measurement + ACT-LR kits (POCT coagulation)
| CIG | Not stated |
| Description / what it is | The hospital needs to rent for 5 years 5 instruments to measure the activated clotting time (ACT) at the patient's bedside, plus the kits/cartridges to run the tests. It is needed to monitor heparin therapy during ECMO, hemodynamics, vascular procedures, neuro-interventional procedures and dialysis. The supply includes quality controls. |
| System / instrumentation | Instrumentation for ACT measurement (5 devices on rental for 60 months); ACT-LR test to be used on compatible instrumentation - typical POCT coagulation device (whole blood) |
| Base amount | Instrumentation: β¬ 3.000,00 annual fee each β β¬ 75.000,00 (5 instruments x 60 months); Kit: β¬ 8,51 each β β¬ 22.977,00 (2.700 tests). Total β¬ 97.977,00 VAT excluded |
| Volumes | 5 devices; 2.700 ACT-LR tests (requirement over 60 months) |
| Duration | 60 months (rental) |
| Required tests | - ACT-LR - quantitative analysis of the activated clotting time (Low Range), for heparin monitoring in ECMO, hemodynamics, vascular procedures, neuro-interventional procedures, dialysis
- Quality control (QC) solutions as needed
|
| Technical requirements | - ACT-LR test (Low Range) for heparin monitoring
- Kit/instrumentation compatibility
- Suitability for ECMO, hemodynamics, vascular, neuro-interventional procedures and dialysis
- Supply of the quality control solutions
|
| Sampling | Not stated |
| Notes | Technical documentation (specifications) not present in the dossier: detailed requirements, award criterion and CIG to be verified on SINTEL. Potential showstopper: five-year rental of 5 dedicated instruments and the need for a compatible ACT-LR range covering all applications (ECMO included). Firsteck competitiveness: it falls within the POCT coagulation focus; assess whether an ACT system with ACT-LR kits exists in the portfolio (own or via partner/OEM). Modest amount (~98k over 5 years). The ACT POCT market is held by few players (Werfen/Hemochron, Abbott/i-STAT, Medtronic/Helena): risk of a specification designed around a single instrument. |
| Sources | - Allegato_3_-_Offerta_economica.pdf: pagina 1
- Allegato_3_-_Offerta_economica.pdf: pagina 2
|
Assessment for Firsteck Bio
The supply concerns instrumentation and kits for ACT (activated clotting time) measurement in point-of-care mode: it therefore falls within the Firsteck focus 'POCT coagulation'. The amount is limited (β¬ 97.977,00 over 60 months) and the volumes modest (2.700 tests). Critical points: the dossier lacks all the technical/administrative documentation (only economic Annex 3), so the CIG, the award criterion, the deadlines and the requirements are unknown; furthermore the ACT-LR segment for ECMO/hemodynamics is dominated by few suppliers and the specification could be designed around a single instrument. It makes sense to assess participation only if Firsteck has (in-house or through a partner) an ACT system with a compatible ACT-LR kit.